DCM Shriram Fine Chemicals Approves 20% Dividend, Concludes Financial Year Results

DCM Shriram Fine Chemicals Approves 20% Dividend, Concludes Financial Year Results

DCM Shriram Fine Chemicals Approves 20% Dividend, Concludes Financial Year Results​

DCM Shriram Fine Chemicals Limited announced the outcomes of its Board meeting held on May 19, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, and recommended a dividend for the fiscal year 2025-26.

The company also approved convening its 55th Annual General Meeting (AGM) via Video Conference/Other Audio Visual Means (OAVM) on Tuesday, July 14, 2026.

Dividend Recommendation and Financial Highlights​

At the Board meeting, the directors recommended a dividend of 20%, equating to Rs. 0.40 per equity share, based on the face value of Rs. 2. This dividend is subject to the approval of the company's shareholders at the ensuing AGM.

The annual results, covering the period ended March 31, 2026, were audited by Kirtane & Pandit LLP, who provided an unmodified opinion on both the Standalone and Consolidated Financial Results.

The consolidated financial results include the financial data of the Holding Company, DCM Shriram Fine Chemicals Limited, and its subsidiary, Daurala Food & Beverages Private Limited.

Financial results for the year ended March 31, 2026, show the following key figures:

Consolidated Financial Position Summary (March 31, 2026)

ParticularsAmount (₹)
Total Current Assets18,590
Total Assets30,356
Total Equity21,101
Total Liabilities19,255
Total Equity and Liabilities30,356

Cash Flow Statement Summary (Year Ended March 31, 2026)

ActivityStandalone (₹)Consolidated (₹)
Cash from Operating Activities7,0563,607
Net Cash from Investing Activities1,0461,066
Net Cash (used in) from Financing Activities5141,455
Net Increase in Cash and Cash Equivalents2001,401

Corporate and Accounting Developments​

The company's financial results reflect the impact of a Composite Scheme of Arrangement that was approved by the Board of Directors on November 14, 2023, and subsequently sanctioned by the National Company Law Tribunal (NCLT) on November 21, 2025. This Scheme involved the amalgamation of Lily Commercial Private Limited with DCM Shriram Industries Limited, and the subsequent demerger of the Chemical and Rayon undertakings of DCMSR into DCM Shriram Fine Chemicals Limited and DCM Shriram Total International Limited, respectively.

During the current year, Daurala Foods and Beverages Private Limited became a wholly subsidiary of the company under the Scheme.

The transaction details reported include:
  • DCMSR transferred net assets aggregating to Rs. 15,336 lakhs and a surplus of Rs. 28,663 lakhs to the company.
  • An investment of Rs. 2,331 lakhs held by DCMSR in the Company was cancelled.

From a corporate action standpoint, the Board of Directors of the Company recommended the distribution of a final dividend of Rs 0.40 per equity share of the face value of Rs. 2 for the financial year ended 2026.

Other significant accounting notes highlight the following movements:
  • A Board Committee allotted 8,69,92,185 equity shares of Rs. 2 each to the shareholders of DCMSR, which were listed with BSE Ltd and National Stock Exchange of India Ltd effective from February 17, 2026.
  • The company recognized an estimated impairment loss of Rs. 533 lakhs when classifying a leasehold land situated in Dehel, Gujarat, as 'Asset Held for Sale.' This loss was subsequently reduced by Rs. 223 lakhs after the land was sold during the year.
  • The Company reversed an input tax credit amounting to Rs. 229.02 lakhs due to the withdrawal of a refund application from the GST authorities, which resulted in a change in underlying circumstances.

DSFCL Stock Price Movement​

On Tuesday, DCM Shriram Fine Chemicals Limited shares edged higher, rallying 4.99% to settle at ₹28.21. The stock saw robust activity, recording a total traded volume of 95,150 shares during the session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top